ABBV Jan 2023 105.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
14.50+0.04 (+0.28%)
As of 10:31AM EDT. Market open.
| Previous close | 14.46 |
| Open | 14.72 |
| Bid | 14.45 |
| Ask | 15.40 |
| Strike | 105.00 |
| Expiry date | 2023-01-20 |
| Day's range | 14.50 - 14.72 |
| Contract range | N/A |
| Volume | 11 |
| Open interest | 1.65k |
- Motley Fool
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
AbbVie (NYSE: ABBV) recently announced a collaboration with Regenxbio (NASDAQ: RGNX) to develop a gene therapy targeting wet age-related macular degeneration. The deal could be worth up to nearly $1.8 billion including milestone payments. In this Motley Fool Live video recorded on Sept. 15, Motley Fool contributors Keith Speights and Brian Orelli discuss why AbbVie is teaming up with Regenxbio.
- Zacks
AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
- Zacks
Pharma Stock Roundup: PFE Booster Jab Gets FDA Nod, JNJ's New Data on COVID-19 Shot
FDA grants EUA to Pfizer (PFE)/BioNTech's COVID-19 vaccine booster shots for limited use. J&J (JNJ) announces phase III data on booster dose of its single-shot vaccine.
© 2021 Verizon Media. All rights reserved.
